Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Grothusen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
CNS Neuroscience & Therapeutics|April 8, 2024
Non-scheduled short-acting opioid to taper off opioids?Renyu Liu, Bonnie Milas, John Grothusen
Translational Perioperative and Pain Medicine|June 7, 2024
Perioperative Opioid Usage Monitoring and WasteRenyu Liu, John Grothusen, Scott Falk
Expert Review of Neurotherapeutics|June 1, 2006
Pathophysiology of complex regional pain syndromeRobert J Schwartzman, Guillermo M Alexander, John Grothusen
European Journal of Medical Research|December 9, 2015
Cerebral reactivity in migraine patients measured with functional near-infrared spectroscopyAhmadreza Pourshoghi, Arash Danesh, David Stuart Tabby, et al.
Translational Perioperative and Pain Medicine|May 16, 2022
Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid ReceptorJohn Grothusen, Wenzhen Lin, Jin Xi, et al.
CNS & Neurological Disorders Drug Targets|December 8, 2022
Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 PathwayJinxi Huang, Yi Zhou, Si Zeng, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2021
Intranasal Salvinorin A Improves Long-term Neurological Function via Immunomodulation in a Mouse Ischemic Stroke ModelDilidaer Misilimu, Wei Li, Di Chen, et al.
Pain Medicine (Malden, Mass.)|February 13, 2008
Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II studyRalph-Thomas Kiefer, Peter Rohr, Annette Ploppa, et al.
Pain Medicine (Malden, Mass.)|February 8, 2008
A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patientsRalph-Thomas Kiefer, Peter Rohr, Annette Ploppa, et al.
Neurochemistry International|April 28, 2020
Kappa opioid receptors internalization is protective against oxygen-glucose deprivation through β-arrestin activation and Akt-mediated signaling pathwayJihong Xu, Fang Chen, Shuyan Wang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
CNS Neuroscience & Therapeutics|April 8, 2024
Non-scheduled short-acting opioid to taper off opioids?Renyu Liu, Bonnie Milas, John Grothusen
Translational Perioperative and Pain Medicine|June 7, 2024
Perioperative Opioid Usage Monitoring and WasteRenyu Liu, John Grothusen, Scott Falk
Expert Review of Neurotherapeutics|June 1, 2006
Pathophysiology of complex regional pain syndromeRobert J Schwartzman, Guillermo M Alexander, John Grothusen
European Journal of Medical Research|December 9, 2015
Cerebral reactivity in migraine patients measured with functional near-infrared spectroscopyAhmadreza Pourshoghi, Arash Danesh, David Stuart Tabby, et al.
Translational Perioperative and Pain Medicine|May 16, 2022
Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid ReceptorJohn Grothusen, Wenzhen Lin, Jin Xi, et al.
CNS & Neurological Disorders Drug Targets|December 8, 2022
Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 PathwayJinxi Huang, Yi Zhou, Si Zeng, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2021
Intranasal Salvinorin A Improves Long-term Neurological Function via Immunomodulation in a Mouse Ischemic Stroke ModelDilidaer Misilimu, Wei Li, Di Chen, et al.
Pain Medicine (Malden, Mass.)|February 13, 2008
Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II studyRalph-Thomas Kiefer, Peter Rohr, Annette Ploppa, et al.
Pain Medicine (Malden, Mass.)|February 8, 2008
A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patientsRalph-Thomas Kiefer, Peter Rohr, Annette Ploppa, et al.
Neurochemistry International|April 28, 2020
Kappa opioid receptors internalization is protective against oxygen-glucose deprivation through β-arrestin activation and Akt-mediated signaling pathwayJihong Xu, Fang Chen, Shuyan Wang, et al.
Pageof 2